Agnes L. Karmaus, Anna L. Kreutz, Oluwakemi Oyetade, et al. Perspectives on variability of in vivo toxicology studies: considerations for next-generation toxicology. Frontiers in Toxicology. 2026;8. doi:10.3389/ftox.2026.1778353
Andreas Natsch, Peter Griem, Amaia Irizar, et al. Derivation of a Point of Departure using NAMs for application in Quantitative Risk Assessment of fragrance materials. Regulatory Toxicology and Pharmacology. 2026:106052. doi:10.1016/j.yrtph.2026.106052
Timothy W. Gant, Alistair Boxall, Daniel Burgwinkel, et al. Building trust in the integration of artificial intelligence into chemical risk assessment: findings from the 2024 ECETOC workshop. Archives of Toxicology. 2026. doi:10.1007/s00204-025-04286-8
Elisabet Berggren, Andrew P. Worth. Managing change while phasing out animal testing in chemical safety assessments – a collection of stakeholder experiences and expectations. NAM Journal. 2026;2:100079. doi:10.1016/j.namjnl.2026.100079
Xiaozhong Huang, Yun Ting Soong, Jiahao Wang, et al. HIVIL: A human <i>in vitro</i> inflammatory liver model recapitulates immune-associated drug effects with high predictivity. NAM Journal. 2025;1:100032. doi:10.1016/j.namjnl.2025.100032
Andrew S. Robertson, Nahid Latif, Imein Bousnina, et al. Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective. Nature Reviews Drug Discovery. 2025. doi:10.1038/d41573-025-00038-6
Monica Piergiovanni, Milena Mennecozzi, Erio Barale-Thomas, et al. Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology. Archives of Toxicology. 2025. doi:10.1007/s00204-024-03922-z
Eike Cöllen, Kristina Bartmann, Jonathan Blum, et al. Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2501091